Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer’s Disease Pathology
- 19 December 2017
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 61 (2) , 619-630
Abstract
Alzheimer’s disease (AD) is characterized by accumulation of amyloid-β plaques that further promotes microglia-mediated neuroinflammatory responses and inflammation in the brain. Emerging data are revealing the relation between gut-associated lymphoiKeywords
This publication has 33 references indexed in Scilit:
- Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2013
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell DevelopmentImmunity, 2010
- Activation of mixed glia by Aβ-specific Th1 and Th17 cells and its regulation by Th2 cellsBrain, Behavior, and Immunity, 2010
- Responses to Amyloids of Microbial and Host Origin Are Mediated through Toll-like Receptor 2Cell Host & Microbe, 2009
- Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse modelNeurobiology of Disease, 2009
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesJournal of Experimental Medicine, 2006
- The Aβ Hypothesis: Leading Us to Rationally-Designed Therapeutic Strategies for the Treatment or Prevention of Alzheimer DiseaseBrain Pathology, 2006
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- Anatomical basis of tolerance and immunity to intestinal antigensNature Reviews Immunology, 2003
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992